Hubei Mailyard Share Co., Ltd. (600107.SS) engages primarily in the research, development, design, production, and sale of clothing, apparel, textiles, and accessories in China and internationally. The company operates through Apparel and Textiles, Medical, and Other segments, offering fine wool textile products and garments; pharmaceuticals and medical devices; steam production and sales; water and electricity resale; house leasing; hotel investments; and medical and transportation services. Founded in 1993 and headquartered in Huangshi, Hubei Province, China, it targets domestic and export markets with approximately 2,274 employees. Recent developments include ongoing litigation and arbitration related to the sale of its subsidiary Qinghai Zhongyou Health Huijia Pharmaceutical Chain Co., Ltd., with a mediation agreement reached in a related equity transfer dispute adjusting payment terms to 20 million yuan by June 2025; the company also faces regulatory investigations by the CSRC into itself and actual controller Zheng Jiping, alongside implementation of other risk warnings on its shares starting May 2025 and reported net losses in 2024 and third-quarter 2025.